 |
|
Copper Perturbation in 2 Monozygotic Twins Discordant for Degree of Cognitive Impairment
Rosanna Squitti, PhD;
Emanuele Cassetta, MD;
Gloria Dal Forno, MD, PhD;
Domenico Lupoi, MD;
Giulia Lippolis, PhD;
Flavia Pauri, MD;
Fabrizio Vernieri, MD;
Antonella Cappa, MD;
Paolo M. Rossini, MD
Arch Neurol. 2004;61:738-743.
Background Recent evidence indicates that peripheral tissue markers can provide information regarding changes affecting cellular metabolism in Alzheimer disease (AD). We previously reported that serum copper levels can discriminate subjects with AD from normal control subjects (with 60% sensitivity and 95% specificity) and from patients with vascular dementia (with 63% sensitivity and 85% specificity).
Objective To study the correlation between AD and serum levels of transition metals and markers of peripheral oxidative stress.
Design Case study.
Setting General hospital inpatient wards and outpatient clinics.
Patients A pair of elderly monozygotic female twins discordant for AD.
Main Outcome Measures Biochemical analyses of peripheral-blood transition metals and indicators of oxidative stress and neurologic and neuropsychological assessments of clinical status for presence of cognitive impairment and AD.
Results Serum copper and total peroxide levels were both 44% higher in the twin with greater cognitive impairment and a diagnosis of AD.
Conclusions The cases reported support the hypothesis of a major involvement of copper and oxidative abnormalities in AD.
From the Departments of Neuroscience (Drs Squitti, Cassetta, Dal Forno, Lippolis, Pauri, Vernieri, Cappa, and Rossini) and Radiology (Dr Lupoi), Associazione Fatebenefratelli per la Ricerc Foundation, Ospedale Fatebenefratelli, Rome, Italy; Clinica Neurologica, Università Campus Biomedico, Rome (Drs Dal Forno and Rossini); Departments of Neurology and Otolaryngology, Università "La Sapienza," Rome (Dr Pauri); and Istituto di Ricovero e Cura a Carattere Scientifico "Centro S. Giovanni di Dio-Fatebenefratelli," Brescia, Italy (Dr Rossini).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Elevated cortical zinc in Alzheimer disease.
Religa et al.
Neurology 2006;67:69-75.
ABSTRACT
| FULL TEXT
Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF {beta}-amyloid, and h-tau.
Squitti et al.
Neurology 2006;67:76-82.
ABSTRACT
| FULL TEXT
Role of Genes and Environments for Explaining Alzheimer Disease
Gatz et al.
Arch Gen Psychiatry 2006;63:168-174.
ABSTRACT
| FULL TEXT
Excess of serum copper not related to ceruloplasmin in Alzheimer disease
Squitti et al.
Neurology 2005;64:1040-1046.
ABSTRACT
| FULL TEXT
Serum Copper: A Biomarker for Alzheimer Disease?
Bush and Strozyk
Arch Neurol 2004;61:631-632.
FULL TEXT
|
